HHS withdraws request for drug importation proposals

The Department of Health and Human Services today withdrew requests for proposals on ways individuals could import prescription drugs from other countries where they are typically cheaper and companies could “reimport” insulin to sell at a lower price. The RFPs were issued by the Trump Administration last year as part of an executive order directed at lowering drug prices. HHS today said it is “not aware that any proposals were received” in response to the RFPs and that it “intends to consider alternatives to the RFPs.”